NCT04106323
A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt No drug interventions Not Available Not Available unknown_status NCT03055611
A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B Not Available Not Available completed NCT06285071
Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors Not Available Not Available enrolling_by_invitation NCT01562587
Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State treatment 1 completed NCT03875547
Post-marketing Surveillance (Use Result Surveillance) With Refixia® Not Available Not Available enrolling_by_invitation NCT00956345
Safety of 40K Pegylated Recombinant Factor IX in Non-Bleeding Patients With Haemophilia B treatment 1 completed NCT02263456
A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B treatment 3 completed NCT01988532
Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia No drug interventions Not Available Not Available completed NCT01272206
Investigating Safety and Pharmacokinetics of NNC 0128-0000-2011 Compared to NNC 0128-0000-2021 in Healthy Male Subjects No drug interventions treatment 1 completed NCT01555749
Investigation of the Pharmacokinetics of NNC172-2021, at Two Different Dose Levels, in Healthy Japanese Subjects No drug interventions treatment 1 completed NCT02300519
Thrombin Generation Numerical Models Validation in Haemophilic Case No drug interventions Not Available Not Available completed NCT05365217
A Research Study Investigating Nonacog Beta Pegol (N9-GP) for Treatment and Prevention of Bleedings in Chinese People With Haemophilia B treatment 3 completed NCT03276130
Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B No drug interventions Not Available Not Available completed NCT02141074
Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B treatment 3 completed NCT03660774
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia No drug interventions Not Available Not Available completed NCT00951873
A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers treatment 1 completed NCT02250560
A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery. Not Available 3 completed NCT00922792
Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B treatment 1 completed NCT01949792
A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors treatment 1 completed NCT02231944
An Open Study to Investigate the Safety and Efficacy of Replenine®-VF in Severe Haemophilia B Patients treatment 3 completed NCT01503567
Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries No drug interventions Not Available Not Available completed NCT01228669
Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B No drug interventions treatment 1 completed NCT01395810
Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 treatment 3 completed NCT03741881
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6) No drug interventions Not Available Not Available completed NCT02568202
Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S) No drug interventions Not Available Not Available completed NCT01234545
Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors Not Available Not Available completed NCT01386528
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B treatment 3 completed NCT01333111
Safety and Efficacy of NNC-0156-0000-0009 in Haemophilia B Patients treatment 3 completed NCT00486278
Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds treatment 2 completed NCT05086575
Observatory of Patients With Haemophilia B Treated by IdElvion® No drug interventions Not Available Not Available recruiting NCT03075670
A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B treatment 1 completed NCT02049099
A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia Care No drug interventions Not Available Not Available completed NCT03690336
Adverse Event Data Collection From External Registries on Nonacog Beta Pegol Not Available Not Available enrolling_by_invitation NCT01220141
Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B Not Available Not Available completed NCT03745924
A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN Not Available Not Available enrolling_by_invitation NCT00853086
Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database Not Available Not Available completed NCT01562457
Intra-subject Variability Following Administrations of Activated Recombinant Human Factor VII in Haemophilia Patients in a Non-bleeding State treatment 1 completed NCT01322620
Survey Evaluating the Psychosocial Effects of Living With Haemophilia No drug interventions Not Available Not Available completed NCT02250573
An Open-study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Subjects Undergoing Surgery treatment 3 completed NCT01467427
Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. treatment 3 completed NCT02241694
To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives No drug interventions Not Available Not Available completed NCT01288391
Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients No drug interventions treatment 1 completed NCT03655340
A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in France Not Available Not Available completed NCT00638001
Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy No drug interventions treatment 4 completed NCT02263469
A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years Not Available 3 completed NCT02084810
Investigating the Bioequivalence of Eptacog Alfa A 6 mg and NovoSeven® in Healthy Male Subjects treatment 1 withdrawn NCT01959555
Project to Update the Study of Congenital Haemophilia in Spain No drug interventions Not Available Not Available completed NCT04645199
National Longitudinal Cohort of Hematological Diseases No drug interventions Not Available Not Available recruiting NCT05932914
Liver Biopsy Following Gene Therapy For Hemophilia No drug interventions Not Available Not Available not_yet_recruiting NCT06399289
Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy prevention 3 recruiting NCT06568302
The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial treatment 3 recruiting NCT03307980
Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B treatment 2 active_not_recruiting NCT03587116
A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%) No drug interventions other 3 active_not_recruiting NCT03938792
Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B treatment 3 active_not_recruiting NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors treatment 3 recruiting NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively No drug interventions other 3 recruiting NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B treatment 3 recruiting NCT05962398
Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222) No drug interventions Not Available Not Available enrolling_by_invitation NCT06634836
Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B No drug interventions Not Available Not Available not_yet_recruiting NCT03861273
A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B treatment 3 active_not_recruiting NCT04731701
Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST) No drug interventions Not Available Not Available completed NCT05568459
A Trial That Evaluates Disease Characteristics in Hemophilia B Adult Male Participants Receiving Prophylaxis With Standard of Care Factor IX Protein (FIX) Replacement Therapy No drug interventions Not Available Not Available recruiting NCT05605678
Hemophilia Non-Interventional Study Prior to SerpinPC Intervention (PRESent-5) No drug interventions Not Available Not Available recruiting NCT05789524
The Efficacy and Safety of SerpinPC in Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B treatment 2 recruiting NCT05789537
A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors treatment 2 recruiting NCT06025552
Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects No drug interventions treatment 1 completed NCT06611436
BeCoMe-9: a Clinical Study of BE-101 for the Treatment of Adults with Moderately Severe or Severe Hemophilia B No drug interventions treatment 1 / 2 not_yet_recruiting NCT06349473
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B) No drug interventions treatment 1 recruiting NCT06379789
A Trial to Learn if REGV131-LNP1265 is Safe and Works to Help the Body Make Clotting Factor in Pediatric, Adolescent and Adult Patients With Hemophilia B No drug interventions treatment 1 / 2 recruiting NCT00195221
Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B No drug interventions Not Available Not Available completed NCT03327779
World Bleeding Disorders Registry No drug interventions Not Available Not Available recruiting NCT01286779
BAX 326 (rFIX) Continuation Study treatment 3 completed NCT00768287
Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia B supportive_care 2 / 3 completed NCT05889754
Reliability and Validity of the Turkish Version of the PedHAL No drug interventions Not Available Not Available not_yet_recruiting NCT03091751
Efficacy and Safety of AlphaNine Versus BeneFIX in Patients With Severe Hereditary Haemophilia B treatment 2 completed NCT05441553
A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients No drug interventions treatment 1 / 2 not_yet_recruiting NCT02807753
The Hemophilia Ultrasound Project No drug interventions Not Available Not Available terminated NCT03186677
Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients treatment 1 completed NCT05980377
Patterns of Hemophilia Care in Assiut Children Patients No drug interventions Not Available Not Available not_yet_recruiting NCT01460147
Osteoporosis and MRI Study in Hemophilia No drug interventions diagnostic Not Available terminated NCT03417245
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors treatment 3 completed NCT00936845
Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study No drug interventions Not Available Not Available completed NCT02035605
A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients treatment 1 completed NCT03185897
Global Epidemiologic Study of Preexisting Immunity to AAV in Adults With Severe Hemophilia No drug interventions Not Available Not Available completed NCT01335061
Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B treatment 3 completed NCT02048111
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B supportive_care 3 withdrawn NCT00947193
Study of Ataluren (PTC124) in Hemophilia A and B treatment 2 terminated NCT00093171
Study Evaluating rFIX; BeneFIX® in Hemophilia B No drug interventions treatment 3 completed NCT02336178
Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China treatment 4 completed NCT02392156
Fc factOrs and Real-World hemophiliA Patient-ReporteD Outcomes Not Available Not Available terminated NCT00484185
Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia B Not Available Not Available completed NCT02618915
Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B No drug interventions treatment 1 / 2 terminated NCT03565237
RIXUBIS PMS India (RIXUBIS PMS) prevention 4 completed NCT05152732
Safety and Tolerability of VGB-R04 in Patients With Haemophilia B No drug interventions treatment 0 recruiting NCT00212459
The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs No drug interventions Not Available Not Available completed NCT05439642
Validation and Reliability of the CHO-KLAT in Turkish No drug interventions diagnostic Not Available unknown_status NCT02396342
Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B No drug interventions treatment 1 / 2 completed NCT05360706
Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B No drug interventions Not Available Not Available active_not_recruiting NCT00866606
Study Evaluating On-Demand Treatment With BeneFIX In Chinese Subjects treatment 3 completed NCT05879549
Comparison of Efficiency of Closed Kinetic Chain Exercises Versus Proprioceptive Exercises Patient With Hemophilia No drug interventions treatment Not Available recruiting NCT05187936
Pre-clinical Models for Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy No drug interventions Not Available Not Available unknown_status NCT05981313
Viscoelastic Properties of Lower Extremity Muscles in Patients With Hemophilia No drug interventions Not Available Not Available not_yet_recruiting NCT02740413
Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort Study No drug interventions Not Available Not Available completed NCT01510418
Socialization of Adult Men With Congenital Hemophilia A or B No drug interventions Not Available Not Available completed NCT02199717
An Institutional Pilot Study to Investigate Physical Activity Patterns in Boys With Hemophilia No drug interventions Not Available Not Available completed NCT06158334
Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®) Not Available Not Available recruiting NCT00716716
Phase I/IIa Study of FIXFc in Hemophilia B Patients treatment 1 completed NCT01507896
BAX 326 Surgery Study in Hemophilia B Patients treatment 3 completed NCT04394286
A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects No drug interventions treatment 1 / 2 terminated NCT01361126
A Safety and Efficacy Study of a Recombinant Factor IX in Patients With Severe Hemophilia B treatment 1 / 2 completed NCT00581126
Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B treatment 4 completed NCT01496274
A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B No drug interventions treatment 2 / 3 completed NCT06120582
Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN) No drug interventions treatment 1 / 2 recruiting NCT03507582
Virtual Reality for Hemophilia No drug interventions other Not Available completed NCT01662531
A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B No drug interventions treatment 3 completed NCT01154231
BeneFIX Drug Use Results Survey [All-Case Surveillance] Not Available Not Available completed NCT00749476
Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX Not Available 4 completed NCT03489291
Dose Confirmation Trial of AAV5-hFIXco-Padua No drug interventions treatment 2 completed NCT03569891
HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients treatment 3 active_not_recruiting NCT03818529
ATHN 8: Previously Untreated Patients (PUPs) Matter Study No drug interventions Not Available Not Available completed NCT02484092
A Gene Therapy Study for Hemophilia B treatment 2 completed NCT00927992
Study Evaluating Liver Transplantation in Haemophilia Patients in Spain No drug interventions Not Available Not Available completed NCT01233440
Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B treatment 1 completed NCT05606640
Gaining Insight Into the Complexity of Pain in Patients With Haemophilia No drug interventions Not Available Not Available completed NCT03533504
Web Accessible Population Pharmacokinetics Service - Hemophilia: Sources of Variability No drug interventions Not Available Not Available enrolling_by_invitation NCT02061072
Web-based Application for the Population Pharmacokinetic Service - Phase 1 No drug interventions Not Available Not Available completed NCT01271868
Study of Recombinant Factor IX Product, IB1001, in Previously Treated Pediatric Subjects With Hemophilia B treatment 3 terminated NCT00835068
Post Marketing Observational Study of Reformulated BeneFIX No drug interventions Not Available Not Available completed NCT02571569
A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B, With or Without Inhibitors basic_science 1 completed NCT02971969
Long-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B No drug interventions Not Available Not Available completed NCT00936312
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study No drug interventions Not Available Not Available completed NCT00515710
LTFU for Gene Transfer Subjects With Hemophilia B No drug interventions Not Available Not Available completed NCT02234310
Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B treatment 3 completed NCT05641610
A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients No drug interventions treatment 1 / 2 not_yet_recruiting NCT06565481
Measurement Properties in People With Hemophilia No drug interventions other Not Available not_yet_recruiting NCT06147414
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders No drug interventions Not Available Not Available not_yet_recruiting NCT01921855
Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors treatment 1 completed NCT02213250
An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B treatment 1 completed NCT03655223
Early Check: Expanded Screening in Newborns No drug interventions Not Available Not Available enrolling_by_invitation NCT01687608
Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B treatment 1 / 2 active_not_recruiting NCT02912143
German Pediatric Hemophilia Research Database No drug interventions Not Available Not Available recruiting NCT03961243
Lentiviral FIX Gene Therapy No drug interventions treatment 1 unknown_status NCT03641703
A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy treatment 1 / 2 terminated NCT00851721
Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor treatment 3 completed NCT03417102
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors treatment 3 completed NCT03995784
Study of Next-Generation Recombinant Factor IX Variant in Adult Subjects With Hemophilia B treatment 2 completed NCT03946384
Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype No drug interventions Not Available Not Available unknown_status NCT05203679
Evaluation of the Safety and Efficacy of Hemophilia B Gene Therapy Drug No drug interventions treatment 3 active_not_recruiting NCT06003387
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs) No drug interventions prevention 3 recruiting NCT02061033
Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease No drug interventions Not Available Not Available unknown_status NCT04272554
AAV Gene Therapy Screening/Observational Protocol (ECLIPSE) No drug interventions Not Available Not Available completed NCT05630651
The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients. No drug interventions treatment Not Available not_yet_recruiting NCT03615053
Personalized Medicine for Canadians With Hemophilia No drug interventions other Not Available recruiting NCT05044845
Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene Therapy No drug interventions Not Available Not Available recruiting NCT04073498
The Safety and Tolerability of SerpinPC in Healthy Men and in Men With Severe Blood Disorders (Haemophilia A and B) treatment 1 / 2 active_not_recruiting NCT00824798
Gait Evaluation in Haemophiliac Patients No drug interventions Not Available Not Available completed NCT01757405
Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen treatment 3 completed NCT05442528
Lead-in Study of VGB-R04 Gene Therapy for Hemophilia B-- An Observational Survey Analysis Study No drug interventions Not Available Not Available not_yet_recruiting NCT00139828
Post Marketing Study in Haemophilia B Patients Using Nonafact® (Human Coagulation Factor IX) treatment 4 completed NCT02418793
A Study of a Long-Acting r-Factor 7a (Factor VIIa) in Adult Men With Hemophilia A or B treatment 1 completed NCT05164471
Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B No drug interventions other 1 / 2 terminated NCT04628871
Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX Not Available Not Available active_not_recruiting NCT05709288
Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old treatment 1 recruiting NCT02938156
UK - EHL Outcomes Registry No drug interventions Not Available Not Available unknown_status NCT00714415
Registry For Patients Treated With BeneFix In Usual Care Setting In Germany Not Available Not Available completed NCT04072237
Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia No drug interventions diagnostic 1 completed NCT04135300
Gene Therapy for Chinese Hemophilia B No drug interventions treatment Not Available active_not_recruiting NCT04541875
Medication Adherence and Non-adherence in Adults With Rare Disease No drug interventions Not Available Not Available withdrawn NCT01090206
Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia No drug interventions screening Not Available completed NCT02190149
Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS Not Available Not Available completed NCT03358836
Joint Health Study No drug interventions Not Available Not Available completed NCT02634918
Ultrasonography in Hemophilic Joint Disease and Serum Markers No drug interventions Not Available Not Available completed NCT03248141
Understanding Hemophilia A and B Drug Dosage Administration Patterns No drug interventions Not Available Not Available terminated NCT05804734
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia Not Available Not Available completed NCT01589848
Study on Von Willebrand Disease and Hemophilia in Cuenca, Ecuador No drug interventions Not Available Not Available completed NCT00037557
Study Evaluating rFIX; BeneFIX in Severe Hemophilia B treatment 3 completed NCT00076557
Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B No drug interventions treatment 1 / 2 terminated NCT05856266
An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog Alfa No drug interventions other 4 terminated NCT05687474
Baby Detect : Genomic Newborn Screening No drug interventions Not Available Not Available recruiting NCT06014320
Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease No drug interventions Not Available Not Available not_yet_recruiting NCT00364182
Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B prevention 3 completed NCT02937831
RIXUBIS Drug Use-Result Survey (Japan) Not Available Not Available completed NCT02922231
Post-Marketing Surveillance (Usage Results Study) of RIXUBIS in Adult and Pediatric Patients With Haemophilia B in South Korea Not Available Not Available completed NCT02554773
An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B treatment 1 / 2 completed NCT00167973
Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use No drug interventions Not Available Not Available completed NCT05487976
Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor treatment 3 unknown_status NCT02695160
Ascending Dose Study of Genome Editing by Zinc Finger Nuclease Therapeutic SB-FIX in Subjects With Severe Hemophilia B treatment 1 terminated NCT01488994
BAX 326 Pediatric Study treatment 2 / 3 completed NCT03855280
Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B treatment 3 completed NCT02402829
A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture No drug interventions Not Available Not Available terminated NCT03054389
Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews No drug interventions Not Available Not Available completed NCT02053792
A Safety and Efficacy Extension Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B No drug interventions treatment 3 completed NCT03369444
A Factor IX Gene Therapy Study (FIX-GT) treatment 1 / 2 terminated NCT00004801
Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency treatment 1 / 2 completed NCT01620801
Hemophilia B Gene Therapy With AAV8 Vector treatment 1 terminated NCT01748201
Viscosupplementation in Patients With Hemophilic Arthropathy No drug interventions treatment 4 completed NCT01440946
Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia B treatment 3 completed NCT01174446
Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B Patients treatment 3 completed NCT04286412
Nonacog Alfa Prophylaxis And Treatment Of Bleeding Episodes In Previously Treated Patients With Hemophilia B treatment 4 completed NCT00093210
Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B No drug interventions treatment 3 completed NCT01128881
IMMUNINE Pre-Treatment Study treatment 4 completed NCT00244114
Study Evaluating Allergic Reactions To Benefix In Hemophilia B Patients No drug interventions Not Available Not Available completed NCT03901755
An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B Not Available Not Available active_not_recruiting NCT01217255
Comparing the Burden of Illness of Hemophilia in the Developing and the Developed World No drug interventions Not Available Not Available completed NCT00979238
Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B No drug interventions other 1 active_not_recruiting NCT06008938
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B Not Available Not Available recruiting NCT00581438
Study Evaluating Approach to Treatment of Haemophilia A and B in Spain No drug interventions Not Available Not Available completed